SMPD1 (Sphingomyelin phosphodiesterase) variants and mutations

SMPD1 (also known as Sphingomyelin phosphodiesterase) is a human protein-coding gene encoding a sphingomyelin phosphodiesterase protein. It hydrolyzes sphingomyelin to ceramide in lysosomes and participates in membrane-lipid turnover and stress signaling. Biallelic loss-of-function variants cause acid sphingomyelinase deficiency, including Niemann-Pick disease types A and B. This analysis covers 1,242 SMPD1 variants and mutations. Of these, 77% have computational variant effect predictions. Disease context includes Niemann-Pick disease type A, Niemann-Pick disease type B, and Niemann-Pick disease. Example SMPD1 variants include P2L, P2R, and P2S.

Variant analysis overview

Variant and mutation evidence

Clinical, disease, and population context

Protein structure and variant hotspots

Data sources

Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.

Notable SMPD1 variants

Examples include P2L, P2R, P2S, P2T, P2P, R3C, R3H, R3L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.